» Articles » PMID: 2526301

Effects of Sodium, Lithium, and Magnesium on in Vitro Binding of [3H]SCH23390 in Rat Neostriatum and Cerebral Cortex

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 1989 May 1
PMID 2526301
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of sodium, lithium, and magnesium on the in vitro binding properties of the D1 antagonist [3H]SCH23390 were examined with membrane preparations from rat neostriatum (CPU; caudate-putamen) and cerebral cortex (CTX). The saturation binding isotherms for both tissues performed in the presence of 120 mM of either Na+ or Li+ revealed an increase in the affinity, as compared to that observed when the incubation buffer was composed of Tris-Cl 50 mM with MgCl2 1 mM alone. For the CPU there were no changes in the maximum binding capacity (Bmax) in the different buffers used. In the case of the CTX, there was a loss of [3H]SCH23390 binding sites when either Na+ or Li+ 120 mM were added to the incubations, suggesting a lack of selectivity of this ligand in the absence of group IA cations. The agonist state of the [3H]SCH23390 binding site was studied in competition experiments with dopamine. The highest agonist affinity was obtained in 50 mM Tris-Cl buffer with 1 mM MgCl2 while the addition of 120 mM of either Na+ or Li+ caused a 3- to 5-fold decrease in the potency of dopamine to compete with specific [3H]SCH23390 binding in both CPU and CTX. The presence of magnesium was essential for the competition experiments; i.e.: a concentration of 1 mM MgCl2 was optimum to obtain dopamine antagonism of ligand binding, while increasing Mg2+ to 2 or 5 mM did not appear to further improve the inhibitions. The results support both agonist and antagonist affinity shifts for the dopamine D1 receptor labeled with [3H]SCH23390.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.

Paetsch P, Greenshaw A Cell Mol Neurobiol. 1993; 13(3):203-15.

PMID: 8242685 PMC: 11566813. DOI: 10.1007/BF00733750.


Dopamine D1 receptors labelled with [3H]SCH23390 in rabbit cerebral cortex and neostriatum. Equilibrium binding, kinetics and selectivity.

Reader T, Grondin L, MONTREUIL B, Dewar K Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(6):617-25.

PMID: 2575710 DOI: 10.1007/BF00717736.


Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.

Paetsch P, Greenshaw A Cell Mol Neurobiol. 1992; 12(6):597-606.

PMID: 1490276 PMC: 11567202. DOI: 10.1007/BF00711239.


Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.

Reader T, Molina-Holgado E, Dewar K Mol Neurobiol. 1992; 6(4):425-50.

PMID: 1285933 DOI: 10.1007/BF02757945.

References
1.
Waddington J . Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems. Biochem Pharmacol. 1986; 35(21):3661-7. DOI: 10.1016/0006-2952(86)90649-0. View

2.
Skarsfeldt T, Larsen J . SCH 23390--a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity. Eur J Pharmacol. 1988; 148(3):389-95. DOI: 10.1016/0014-2999(88)90117-3. View

3.
Molloy A, Waddington J . Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology (Berl). 1984; 82(4):409-10. DOI: 10.1007/BF00427697. View

4.
Boyson S, McGonigle P, Molinoff P . Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci. 1986; 6(11):3177-88. PMC: 6568493. View

5.
Seeman P, Ulpian C, Grigoriadis D, Buchman O . Conversion of dopamine D1 receptors from high to low affinity for dopamine. Biochem Pharmacol. 1985; 34(1):151-4. DOI: 10.1016/0006-2952(85)90116-9. View